title: Asialoglycoprotein receptor mediated hepatocyte targeting - strategies and applications.
abstract: Hepatocyte resident afflictions continue to affect the human population unabated. The asialoglycoprotein receptor (ASGPR) is primarily expressed on hepatocytes and minimally on extra-hepatic cells. This makes it specifically attractive for receptor-mediated drug delivery with minimum concerns of toxicity. ASGPR facilitates internalization by clathrin-mediated endocytosis and exhibits high affinity for carbohydrates specifically galactose, N-acetylgalactosamine and glucose. Isomeric forms of sugar, galactose density and branching, spatial geometry and galactose linkages are key factors influencing ligand-receptor binding. Popular ligands for ASGPR mediated targeting are carbohydrate polymers, arabinogalactan and pullulan. Other ligands include galactose-bearing glycoproteins, glycopeptides and galactose modified polymers and lipids. Drug-ligand conjugates provide a viable strategy; nevertheless ligand-anchored nanocarriers provide an attractive option for ASGPR targeted delivery and are widely explored. The present review details various ligands and nanocarriers exploited for ASGPR mediated delivery of drugs to hepatocytes. Nanocarrier properties affecting ASGPR mediated uptake are discussed at length. The review also highlights the clinical relevance of ASGPR mediated targeting and applications in diagnostics. ASGPR mediated hepatocyte targeting provides great promise for improved therapy of hepatic afflictions.
authors.affiliation: Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology (Elite status), N. P. Marg, Matunga (East), Mumbai 400019, India.
authors.forename: Anisha A
authors.initials: AA
authors.lastname: D'Souza
authors.affiliation: Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology (Elite status), N. P. Marg, Matunga (East), Mumbai 400019, India. Electronic address: pvdevrajaran@gmail.com.
authors.forename: Padma V
authors.initials: PV
authors.lastname: Devarajan
mesh_terms: D000818:Animals; D037263:Asialoglycoprotein Receptor / Q000378:metabolism*; D050260:Carbohydrate Metabolism; D002241:Carbohydrates / Q000737:chemistry*; D004337:Drug Carriers / Q000737:chemistry* / Q000378:metabolism*; D016503:Drug Delivery Systems / Q000379:methods*; D004705:Endocytosis; D005690:Galactose / Q000737:chemistry / Q000378:metabolism; D005936:Glucans / Q000737:chemistry / Q000378:metabolism; D022781:Hepatocytes / Q000378:metabolism*; D006801:Humans; D008024:Ligands; D008958:Models, Molecular; D049329:Nanostructures / Q000737:chemistry; D004364:Pharmaceutical Preparations / Q000008:administration & dosage
chemical_list: D037263:Asialoglycoprotein Receptor; D002241:Carbohydrates; D004337:Drug Carriers; D005936:Glucans; D008024:Ligands; D004364:Pharmaceutical Preparations; C009109:pullulan; D005690:Galactose
keywords: Asialoglycoprotein receptor; Galactose; Hepatocytes; Ligands; Pullulan; Sugars